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Endowment of pH responsivity to anticancer peptides is a promising approach to achieve better 
selectivity to cancer tissues.  In this research, a template peptide was designed based on magainin 2, an 
antimicrobial peptide with anticancer activity, and a series of peptides were designed by replacing 
different numbers of lysine with the unnatural amino acid, 2,3-diaminopropionic acid (Dap), which has a 
positive charge at weakly acidic pH in cancer tissues, but is neutral at physiological pH 7.4.  These 
Dap-containing peptides are expected to interact more strongly with tumor cells than with normal cells 
because 1) a weakly acidic condition is formed in tumors, and 2) the membrane of tumor cells is more 
anionic than that of normal cells.  While all examined peptides showed potent cytotoxicities to 
multidrug-resistant cancer cells at a weakly acidic pH (ED50 ~5 µM), the toxicity was decreased with an 
increase in the number of Dap at pH 7.4 (8 Dap residues resulted in ED50 ~60 µM).  Furthermore, the 
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introduction of Dap reduced cytotoxicity against normal cells.  Thus, Dap introduction significantly 
improved cancer targeting due to a pH-dependent charge shift.  Fluorescence imaging and model 
membrane experiments supported this charge shift model. 
 
Introduction 
Cancer is one of the most common fatal disease around the world.  It ranked as the first or second cause 
of death in people under 70 of age in over 90 countries in 2015.[1]  Despite considerable efforts, there are 
many barriers to overcome the disease with chemotherapy, in particular side effects[2] and drug 
resistance.[3, 4]  Therefore, drugs with new modes of action are urgently needed. 
 Natural antimicrobial peptides play an important role in the innate immunity of plants and 
animals, including humans.[5]  These peptides typically have many basic residues and cationic 
amphipathic structures suitable for interaction with the anionic cell membranes of microorganisms.  
Several antimicrobial peptides also have anticancer activity.[6]  Cells acquire little resistance to 
anticancer peptides because they exert cytotoxicity by permeabilizing lipid bilayers without interacting 
with specific receptors.[7]  Because of their activities toward multidrug-resistant cancer cells, anticancer 
peptides have been researched as promising candidates for cancer treatment.  While cationic anticancer 
peptides target cancer cells based on the anionic charges of cancer cell cellular membranes,[8-10] their 
insufficient cell selectivities to cancer cells remain problematic, and they are also toxic to normal cells.[9] 
   A promising approach for better tissue selectivity is endowment of pH responsivity to 
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anticancer peptides.  The pH value in tumor tissue (5.6 - 6.8[11] or 6.2 - 6.9[12]) is lower than that in 
normal tissue (~ 7.4).  This is achieved primarily due to activation of the Na+/H+ exchanger and the 
H+/lactate cotransporter [12].  The proton secretion ability increases with tumor aggressiveness[12].  
Metastatic or multidrug-resistant cancer tissues are considered to have even lower pH than other cancer 
tissues.[11, 13]  In our previous research, the acidic environment in cancer tissues was used to improve the 
selectivity of F5W-substituted magainin 2 (MG),[14] a well-studied anticancer peptide isolated from 
Xenopus laevis.[15]  A peptide with larger cationic charges at a weakly acidic pH than at neutral pH 
should exhibit stronger electrostatic interaction with anionic membranes in cancer tissues.  Such acidity 
responsive tumoricidal (ART) peptides are expected to exert more potent effects against progressed 
cancers.  We previously designed an ART peptide by introducing 6 His residues (pK! ~ 6.0) into an 
MG analog,[14] but the anticancer activity was not sufficient.  
 In this research, we introduced 2,3-diamino propionic acid (Dap, Figure1a) residues into a 
MG-based template peptide to improve pH responsivity.  Dap is a non-proteinogenic amino acid found 
in several species of plants,[16] biosynthesis of antibiotics[17] and meteorites.[18]  The pK! value of the 
Dap side chain in a peptide is ~ 6.3,[19] so it is more sensitive to acidification in cancer tissues than His.  
The template peptide was designed by introducing Lys residues into MG, and a series of peptides were 
generated by replacing several lysine residues with Dap. 
 While all peptides exhibited potent cytotoxicities to a human pancreas carcinoma cell line 
PANC-1 at pH 6.0 (ED50 ~ 5 µM), the toxicity was decreased with an increase in the number of Dap 
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residues at pH 7.4 (ED50 ~ 60 µM for a peptide with 8 Dap residues).  Furthermore, the introduction of 
Dap also reduced cytotoxicity against normal human embryonic kidney cells 293 (HEK293) and 




The template peptide 0Dap was designed based on MG.  Four Lys residues were introduced into the 
hydrophilic face of helix of MG instead of Gly3, Ala15, Gly18, and Glu19 and the C-terminal carboxyl 
group was amidated to increase the net positive charge (Table 1, Figure S1 for the helical wheel diagram).  
Additionally, Met21 was replaced with norleucine (Nle, Figure 1b) to avoid Met oxidization.  
Dap-containing peptides were designed by replacing cationic Lys residues (pK! ~ 10) of 0Dap with 
pH-responsive Dap residues (pK!~ 6.3) named based on their Dap numbers (Table 1).  0Dap is 
expected to have + 8.5 and + 9.5 positive charges at physiological pH 7.4 and acidic pH 6.0, respectively, 
due to amino groups of eight Lys side chains, the N-terminus, and the side chain of His.  Dap residue 
has a lower pKa value than Lys.  Dap-containing peptides are expected to have larger responsive charge 
shifts (Table 1). 
 
pH-dependent cytotoxicity 
Multidrug-resistant PANC-1 cells derived from a human pancreatic ductal carcinoma were utilized to 
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evaluate the anticancer activity of the peptides.[3]  The cells were confirmed to be resistant to mitomycin 
C, a typical anticancer drug, both at pH 6.0 and 7.4 (Figure 2). 
The cytotoxicity of each peptide was examined at different extracellular pH conditions between 6.0 and 
7.4 (Figure 3).  The EC50 value was calculated by fitting the data to the equation 
 
	 V	＝	
!""!!( !!!!")!	 	 	 	 	 (1)	
 
(V, C and a represent cellular viability, peptide concentration and cooperativity index, respectively) for 
each condition (Figure 3).  Each peptide exhibited comparable potent toxicity at pH 6.0 (EC50 of ~5 
µM), while the toxicity was decreased with an increase in the number of Dap residues at pH 7.4 (EC50 of 
~9 µM and ~ 60 µM for 0Dap and 8Dap, respectively).  Thus, Dap introduction endowed ART activity 
toward the peptide. 
 The toxicity of each peptide against normal GM and HEK293 cells was determined compared 
with that against cancer PANC-1 cells (Figure 4, Table 2).  The kidney-derived GM cells were 
examined both at weakly acidic pH 6.0 and physiological pH 7.4 because the normal kidney has acidic 
regions in certain cases.[20]  While all peptides exhibited PANC-1 selectivity at both pH 6.0 and 7.4, it 
increased with the number of Dap residues.  These results suggested enhanced selectivity of 
Dap-containing peptides to cancer cells due to their sensitivity to low pH in addition to stronger 
electrostatic interactions to the more anionic cancer plasma membranes. 
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Localization of peptides in PANC-1 cells 
To investigate the peptide cytotoxicity mechanisms, Alexa488 conjugated 0Dap and 8Dap were 
synthesized.  The cytotoxicities of these labeled peptides against PANC-1 cells were comparable to 
those of the free-peptides (Figure S2).  Therefore, we assume that the labeled peptides have similar 
action mechanisms in the cells as the corresponding unlabeled peptides. 
 PANC-1 cells were incubated with 0.2 µM of the labeled peptides for 24 h in pH-adjusted 
medium to evaluate the peptide uptake from the fluorescence intensity of each cell (Figure 5).  At pH 
6.0, both peptides exhibited similar uptake, whereas at pH 7.4, 8Dap exhibited weaker uptake, in good 
agreement with the cytotoxicity (Figure 3).  At pH 6.0, 0Dap exhibited a slightly weaker signal than at 
pH 7.4, possibly because the ATP-dependent active uptake by cells was weakened at pH 6.0. 
 PANC-1 cells were also treated with 0.2 µM of the labeled peptides with EC50 concentrations 
of the unlabeled peptides. Mitochondria were stained with Mito Tracker, a membrane 
potential-dependent mitochondrial dye (Figure 6).  Cells were time-lapse imaged at pH 6.0 or 7.4 for 30 
minutes, and rapid internalization was observed under the conditions in which potent cytotoxicities were 
observed (0Dap at both pH values and 8Dap at pH 6.0).  The internalization of the peptides was 
completed in a few minutes and the fluorescence of Mito Tracker vanished simultaneously, indicating 




To elucidate the mechanisms of the pH dependence, the interactions between liposomes and peptides 
were examined.  The affinity of the peptides to lipid bilayers was evaluated based on the blue-shift of 
Trp fluorescence, which is known to indicate less polar environments in membranes.  
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) were used as zwitterionic and anionic 
phospholipids.  Two lipid compositions of large unilamellar vesicles (LUVs) (POPC: POPS: cholesterol 
= 8: 1: 1 or 9: 0: 1) were prepared to measure the membrane binding of 0Dap or 8Dap (Figure 7).  The 
requirement of negatively charged lipids (POPS) for binding of the peptides indicates the importance of 
electrostatic interactions, as mentioned in the literature.[21]  While both peptides exhibited similar 
binding affinities at pH 6.0 (Figure 7a), 8Dap was less likely to bind to anionic lipid membranes than 
0Dap at pH 7.4 (Figure 7b). 
 The secondary structures of the peptides in the absence and presence of vesicles were estimated 
by CD (Figure 8 and Table 3).  At pH 6.0, both peptides with LUVs (L/P = 100) exhibited 
double-minima at 208 and 222 nm, indicating helical structures; however, 8Dap was significantly less 
structured (Figure 8a).  On the other hand, at pH 7.4, both peptides assumed similar helical structures in 
the presence of LUVs (Figure 8b).  Fluoride did not significantly affect the peptide–membrane 
interaction because in NaCl buffer, similar [θ]222 value of ~22,000 deg cm2 dmol–1 was observed for 
0Dap at pH7.4 in the presence of the LUVs., although CD spectra below 200 nm could not be measured 
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in NaCl buffer. 
 Peptide-induced leakage of calcein encapsulated in LUVs was determined to evaluate the 
membrane-permeabilizing activities of the two peptides (Figure 9).  The leakage was not dependent on 





As shown in previous studies, cationic anticancer peptides possess cancer selectivity[6, 9, 10] because they 
have more cancer cell anionic plasma membranes than those of normal cells due to larger surface 
expressions of phosphatidylserine, sialic acid and glycosaminoglycans.[9]  Consistently, all peptides 
examined in this study were cancer cell-selective.  In addition to the difference in surface charge of 
membranes, ART peptides are assumed to have another mechanism of cell selectivity.  The pH values 
just above the lipid membranes decreased as the anionic components of the membranes increased.[14, 22]  
ART peptides become more cationic just above cancer cell membranes than above normal cell 
membranes.  Therefore, ART peptides have the potential to exhibit cancer selectivity even in the same 
pH medium.  There are other factors that may influence this cancer selectivity depending on the 
mechanisms of action of the peptide.  For example, some (but not all) antimicrobial peptides induce 
oxidative stress in the target cell.  Since the distinct metabolism of cancer cells can also induce greater 
oxidative stress, it is possible that additional stress caused by a peptide cannot be tolerated to the extent it 
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is in healthy cells. 
 
Tissue selectivity 
The strong pH-dependence of cytotoxicity for Dap-rich peptides to PANC-1 cells (Figure 3) indicates 
that Dap protonation upon medium acidification is coupled with the formation of cationic and toxic 
peptide species.  Here, a phenomenological two-state model was used to describe the observed 
pH-dependent cytotoxicity of 8Dap.  Assuming that the peptide exists in two states, a more cationic, 
more toxic form and a less cationic, less toxic form, their equilibrium can be expressed as 
 
more toxic form ⇆ less toxic form + nH+   (2)	
 
with a single apparent acid dissociation constant 𝐾!!"" where 
 
  (𝐾!!"")! = [!"#$ !"#$% !"#$]!"## !"#$% !"#$ [!!]!    (3) 
 
The fraction of the more toxic form 𝐹!"#$ in the total peptide is calculated as 
 
  𝐹!"#$  = !!"!(!"!!"!!"")!!	 	 	 	 	 (4) 
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The fraction of the less toxic form 𝐹!"#$ equals to 1–𝐹!"#$.  The parameter n was semiempirically 
treated as an adjustable parameter (the Hill constant), which reflects the degree of cooperativity in the pH 
dependence.  We found that n ~ 1 gave the best fit for the pH-dependent cytotoxicity of 8Dap (data not 
shown); therefore, n was fixed to unity in the following analysis.  Analogous to eq. (1), the cell viability 
V was calculated as a product of viabilities originating from the less toxic form and the more toxic form 
 
   𝑉 ＝ !""!!(!∙!!"#$!"!"!"#$ )! !!(!∙!!"#$!"!"!"#$ )! 	 	 	 	 (5) 
 
where 𝐸𝐶!"!"#$ and 𝐸𝐶!"!"#$ mean the 𝐸𝐶!" values of the more toxic and less toxic forms, respectively.  
The 𝑝𝐾!!"", 𝐸𝐶!"!"#$, 𝐸𝐶!"!"#$ and a values were estimated by globally fitting the observed 𝑉 values at 
different pH points (Table 4, Figure 10).  As shown in Figure 10, the best fit well reproduced the 
viability data at each pH, indicating that the two-state model can explain the results well.  Although the 
above phenomenological model oversimplifies the actual 8Dap protonation equilibria involving 
intermediate species, it provides rough estimates for the EC50 values of the more toxic form (~4 µM) and 
the less toxic form (~100 µM). 
The effective pKa values of Dap-containing peptides may actually be lower than the pKa of Dap (~6.3).  
This can be a beneficial effect and actually enhance the selectivity of the peptides.  This is because, 
according to the Gouy-Chapman model, the interface region approaching a negatively charged surface (as 
in the PANC-1 cells and POPS-containing LUVs) will have lower pH than the bulk. 
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Mechanisms of cytotoxicity 
Overall, the cellular uptake (Figure 5) and cytotoxicity (Figure 3) of the peptides appear to be correlated 
with their binding affinity to plasma membrane-mimicking anionic lipid bilayers (Figure 7).  For 
example, at acidic pH, 8Dap exhibited higher affinity to anionic membranes via electrostatic interaction, 
and was efficiently uptaken into the cytosol, leading to cytotoxicity.  On the other hand, at neutral pH, 
8Dap exhibited lower affinity to the vesicles, poor cellular uptake, and lower cytotoxicity.  As indicated 
by the disappearance of Mito Tracker fluorescence, the internalized peptides could exert cytotoxicity via 
mitochondrial damage similarly to magainins, as previously reported.[23]  It should be noted that the 
extracellular pH does not influence the intracellular pH, so only the amounts of uptaken peptides 
determine the mitochondrial damage.  To further examine cytotoxic mechanism of Dap-containing 
peptides, the ability of the peptides to induce endosomal escape of cargo was examined by using a 
FITC-dextran (Supporting Figure S3).  The percentage of cells that exhibited dextran diffusion into the 
cytosol was 10% or smaller even in the presence of the peptides. 
 The membrane-bound 8Dap exhibited a flattened CD signal at acidic pH despite its membrane 
affinity being comparable to that of 0Dap.  The lower helicity of the Dap-containing peptide than that of 
its Lys analog was also reported in a previous study.[24]  The protonated Dap amino group can form a 
hydrogen bond with a carbonyl group of the main chain,[25] resulting in the formation of a stable 
six-membered ring.  This hydrogen bond may stabilize non-helical conformations by perturbing 
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hydrogen bonds in the main chain. 
 Interestingly, 8Dap exhibited lower membrane-permeabilizing activities than 0Dap at both 
physiological and acidic pH values, presumably because the shorter Dap side chain in the hydrophilic 
surface leads to lower hydrophobicity of the peptide compared to 0Dap.  The lower membrane 
permeabilization activity of 8Dap is consistent with its lower cytotoxicity at physiological pH, while its 
higher cytotoxicity at acidic pH despite a similar membrane-permeabilizing activity to that at pH 7.4 
suggests the presence of cytotoxic mechanisms other than direct peptide–bilayer interactions. 
 
Conclusion 
We succeeded in endowing ART properties to the magainin-based peptide 0Dap to enhance its cancer 
selectivity.  Dap incorporation reduced undesired toxicity to normal cells at physiological pH, while 
maintaining anticancer activity to multidrug-resistant cancer cells at tumor tissue-specific acidic pH.  At 
acidic pH, 8Dap exhibited higher affinity to plasma membrane-mimicking lipid bilayers and was accordingly 
internalized into cells more effectively than at physiological pH.  The affinities depended on the electric 
charge of Dap.  Fluorescence imaging revealed that mitochondria were presumably a major target of the 
peptides.  In summary, 8Dap was internalized into cells in a pH-dependent manner with less plasma 
membrane damage and depolarized the mitochondria.  Incorporation of Dap residues into anticancer peptides 
will lead to ART peptides that can open a new avenue for treatment of multidrug-resistant cancers with 




Peptide synthesis and purification 
The peptides were synthesized by a standard fluoren-9-ylmethoxycarbonyl-based solid phase method as 
described previously.[14, 26]  Alexa488 conjugated peptides (0Dap and 8Dap) were synthesized by mixing 
a DMF cocktail containing peptide resin, Alexa Fluor488 carboxylic acid (tris salt)	(Life Technologies, 
Carlsbad, CA) and HATU for 48 h.  They were deprotected and cleaved from resin with reagent K[26] 
and purified, and purity was confirmed with reversed-phase high performance liquid chromatography.  
Purified peptides were identified with matrix-assisted laser desorption ionization mass spectrometery.  
The concentrations of the peptides were determined based on absorbance at 280 nm.[27] 
 
Cell culture 
PANC-1, HEK293 and GM cells were cultured at 37˚C with 5% CO2 in a humidified incubator.  
PANC-1 and HEK293 cells were cultured in DMEM medium containing 10 % FBS, 10 units/mL 
penicillin G, and 10µg/mL streptomycin.  GM cells were cultured in CS-C complete medium containing 
the same additive agents described above.  Cells were passaged every 3-4 days. 
 
pH-dependent cytotoxicity 
Cells were plated on a 96-well plate and incubated in a culture medium for 24 h at neutral pH.  HEPES 
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and MOPS were added at 10 mM and HCl was used to adjust the pH of the medium in the cytotoxicity 
experiments and the medium was incubated in a humidified atmosphere over the weekend to achieve CO2 
equilibrium in the atmosphere.  After treatment with peptide solutions in the pH-adjusted medium, the 
cells were incubated for 24 h without CO2 supply.  The change in pH was negligible (≤ 0.1)  Cell 
viability was determined by the Cell Proliferation Reagent WST-1 (Roche, Mannheim, Germany). [28]  
The medium was gently replaced with 110 µL of fresh pH-adjusted medium containing 10 µL of WST-1 
reagent.  The pH value of the WST-1-containing culture was adjusted to 7.4 to avoid a weak WST-1 
reaction at acidic pH.[29]  Several hours (3 h for PANC-1, 2.5 h for HEK293,4 h for GM in pH6.0 and 2 
h for GM in pH 6.0) after replacement, the absorbance was measured through a 450‒655-nm filter.  
HEK293 cells were treated only at pH 7.4 because the cells incubated even without the peptides at pH 6.0 
did not show enough absorbance in the WST-1 assay. 
Peptide uptake in PANC-1 cells 
PANC-1 cells (5,000 cells/well) were plated on 96-well optical bottom plates with a coverglass base, 
allowed to adhere and treated with 0.2 µM Alexa488-conjugated 0Dap or 8Dap in the same manner as for 
the cytotoxicity assay.  In this assay, cells were treated at two pH values, 6.0 or 7.4.  After 24 h 
treatment with Alexa488-conjugated peptides, images of the cells were acquired with a confocal 
microscope (C1si, Nikon, Tokyo, Japan).  A region of interest (ROI) was manually defined for each cell 
to evaluate uptake of the peptides from the fluorescence intensity of Alexa488 (n = 100). 
Mitochondrial potential monitoring 
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PANC-1 cells (35,000 cells/compartment) were seeded on a 35 mm glass bottom 4-compartment dish 
(Greiner Bio-One, Frickenhausen, Germany) and incubated for 24 h before being stained and observed.  
Thirty minutes before the start of peptide treatment, Mito Tracker Red CMXRos (Thermo Fisher 
Scientific, Bremen, Germany) was added to each compartment at a final concentration of 50 nM.  After 
removal of the culture medium, cells were treated with EC50 concentrations of free peptides and 0.2 µM 
Alexa488-conjugated peptides.  The fluorescence of Alexa488 and Mito Tracker were monitored with a 
confocal microscope for 30 min. 
LUVs 
LUVs were prepared according to a previous report unless otherwise noted.[14]  Briefly, PC and 
cholesterol were purchased from Sigma (St. Louis, MO) and PS were from Avanti (Alabaster, AL), 
respectively.  A lipid film was hydrated with a buffer (10 mM Tris/150 mM NaCl/1 mM EDTA, pH 7.4) 
or calcein solution (70 mM calcein, pH7.4) and vortex-mixed to produce multilamellar vesicles.  The 
suspension was incubated at 50 ˚C for 1 h while being vortexed every 15 minutes and then extruded 
through polycarbonate filters (100 nm pore size filter, 31 times).  The lipid concentration was 
determined in quadruplicate by phosphorus analysis.[30] 
Membrane binding 
The binding of 0Dap and 8Dap to LUVs was estimated on the basis of Trp fluorescence as mentioned 
elsewhere[14].  Peptide solutions (4 µM) were titrated with PC/PS/cholesterol or PC/cholesterol 
liposomes in the Tris buffer (pH 6.0 or pH 7.4) mentioned above at 30 °C while the fluorescence spectra 
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of the Trp residue were recorded at an excitation wavelength of 280 nm on a Shimadzu RF-5300 
spectrofluorometer (Kyoto, Japan).  Blank spectra (LUVs) were subtracted and volume correction for 
dilution (up to 4 %) was performed.  Experiments were carried out in duplicate. 
CD spectra 
CD spectra of 10 µM of 0Dap and 8Dap in the absence and the presence of LUVs (POPC: POPS: chol = 
8: 1: 1) in Tris buffer (contains NaF instead of NaCl) were measured on a Jasco J-820 apparatus at 30 ºC 
using a 1-mm path length quartz cell to minimize the absorbance due to buffer components as reported 
previously,[14].  We confirmed that the light scattering due to a high concentration of LUVs did not 
distort the spectrum.[31]  Eight scans were averaged for each sample.  The blank spectra (LUV 
suspension or buffer) were subtracted.  The % helicity was calculated with ellipticity at 222 nm 
according to a previous report.[32]  
Calcein release assay 
The membrane permeabilizing activity was estimated by calcein leakage.[33]  The release of calcein from 
LUVs in Tris buffer (pH 6.0 or 7.4) with or without 1 µM of each peptide was fluorometrically monitored 
at an excitation wavelength of 490 nm and an emission wavelength of 517 nm.  The maximal 
fluorescence intensity corresponding to 100% leakage was determined by addition of 10% Triton X-100 
(20 µL) to the sample (2 mL).  The final concentration of lipid in each sample was 5.37 µM.  The 
apparent percent leakage value was calculated according to 
    %apparent leakage = 100 (𝐹 − 𝐹!) ∕ (𝐹! − 𝐹!)   (5) 
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where F and 𝐹! denote the fluorescence before and after addition of the detergent, respectively and 𝐹! 
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Table 1 Sequences of MG and MG-based peptides used in this study 
Peptide Sequencea Chargeb Difference 
pH 6.0 pH 7.4 
MG GIGKWLHSAKKFGKAFVGEIMNS + 4.5 + 3.5 1.0 
0Dap GIKKWLHSAKKFGKKFVKKIZNS-NH2 + 9.5 + 8.5 1.0 
2Dap GIKXWLHSAKKFGXKFVKKIZNS-NH2 + 8.8 + 6.7 2.1 
4Dap GIKXWLHSAXKFGXKFVKXIZNS-NH2 + 8.1 + 4.8 3.3 
6Dap GIKXWLHSAXXFGXKFVXXIZNS-NH2 + 7.5 + 3.0 4.5 
8Dap GIXXWLHSAXXFGXXFVXXIZNS-NH2 + 6.8 + 1.1 5.7 
a Introduced Lys residues are underlined in the 0Dap sequence.  X (hatched) and Z represent Dap and Nle residues, 
respectively. 
b The charges were estimated based on pH and 𝑝𝐾! values, assuming 𝑝𝐾! values of 6.3, 6.0, and 7.4 for Dap, His, 
and the N-terminal amine, respectively. 
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Table 2 Summary of EC!" valuesa 
  pH 6.0  pH 7.4 
cells PANC-1 GM  PANC-1 GM HEK293 
0Dap 6.4 ± 0.2 7.6 ± 2.1  9.1 ± 0.3 25.6 ± 4.5 15.7 ± 1.8 
2Dap 2.7 ± 0.5 25.9 ± 0.6  14.7 ± 0.6 50.3 ± 0.9 27.2 ± 3.1 
4Dap 2.5 ± 0.1 21.1 ± 0.3  35.7 ± 0.7 91.6 ± 5.9 > 100 
6Dap 2.5 ± 0.4 19.8 ± 0.3  55.0 ± 1.8 > 100 > 100 
8Dap 5.2 ± 0.8 19.2 ± 0.4  61.4 ± 1.7 > 100 > 100 
aEC50 values of each peptide against cancer and normal cells were calculated at pH 6.0 or 7.4. 










aHelicities of 0Dap or 8Dap with liposomes (L/P = 100) were calculated based on ellipticities at 222 nm.[32] 
Helicity/% pH 6.0 pH 7.4 
0Dap 63 73 
8Dap 17 63 
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𝑝𝐾!!"" 𝐸𝐶!"!"#$ (µM) 𝐸𝐶!"!"#$ (µM) a 




Figure 1 Structures of Dap (a) and Nle (b).  Nonproteinogenic amino acid Dap and Nle were introduced into an 
anti-cancer peptide in order to endow pH-responsivity and prevent Met oxidization, respectively. 
 
Figure 2 Drug resistance of PANC-1 cells toward the typical anticancer agent mitomycin C (MMC).  PANC-1 
cells were incubated with MMC solution for 24 h to confirm the drug-resistance of the cells.  The error bars 
represent S.D. (n = 3).  PANC-1 exhibited high viability after MMC treatment both at pH 6.0 and 7.4, 
confirming the high drug-resistance of PANC-1 cells. 
 
Figure 3 The relationship between medium pH and EC!" values for PANC-1 cells.  The cytotoxicity assay for 
each peptide was conducted against PANC-1 cells and the EC50 value at each pH was calculated with equation 
(1).   The error bars represent S.D. (n = 3).  While Dap introduction did not alter cytotoxicity greatly at 
weakly acidic pH, it reduced toxicity of the peptides significantly at physiological pH. 
 
Figure 4 The relationship between peptide concentration and cell viability.  The viability of each cell type under 
each condition was compared for 0Dap (a), 2Dap (b), 4Dap (c), 6Dap (d), and 8Dap (e).  The error bars 
represent S.D. (n = 3).  While 0Dap showed little pH-dependence, it increased with the Dap number. 
 
Figure 5 Distribution of fluorescence intensity of each cell type treated with the peptides.  Fluorescence 
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intensity for each cell type treated with the labeled peptides was quantified by a manually defined ROI, and the 
distribution of its fluorescence intensity of the ROI is shown. 
 
Figure 6 Cellular uptake of peptides and changes in mitochondrial membrane potential.  a, b, c, d, e and f 
represent 0Dap/pH 6.0, 0Dap/pH 7.4, 8Dap/pH 6.0, 8Dap/pH 7.4, vehicle/pH 6.0 and vehicle/ pH 7.4, 
respectively.  Red and green images indicate Mito Tracker and Alexa488-labeled peptides, respectively.  The 
concentrations of the unlabeled peptides under each condition for a, b, and c were 6 µM, 9 µM, 5 µM and 60 µM, 
respectively, and the concentration of the labeled peptides was 0.2 µM.  Under conditions with high toxicity, 
rapid internalization of peptides concomitant with the dissipation of mitochondrial membrane potential (arrows) 
was observed (a–c).  The times after peptide treatments are indicated in the figures. 
 
Figure 7 pH-dependent membrane binding of 0Dap and 8Dap at pH 6.0 (a) and 7.4 (b).  The wavelengths at the 
peaks of fluorescence spectra are plotted as a function of the lipid to peptide molar ratio (L/P).  While the 
peptides did not bind to LUV without anionic components, they interacted well with LUV containing 10 % of 
anionic POPS at both pH values.  At pH 7.4, 8Dap showed lower affinity to LUV than 0Dap. 
 
Figure 8 CD spectra of 0Dap and 8Dap at pH 6.0 (a) and 7.4 (b).  The CD spectra of 0Dap or 8Dap at pH 6.0 
and 7.4 were measured.  While the peptides formed random coil structures in solution, they formed helical 
structures in the presence of LUVs containing 10% anionic POPS.  The helicities with LUVs were similar, 
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except for 8Dap at pH 6.0. 
 
Figure 9 Permeabilization of lipid bilayers induced by peptides.  Permeabilization induced by the peptides was 
evaluated by calcein leakage from plasma membrane-mimicking lipid bilayers (POPC: POPS: chol = 8: 1: 1).  
The percent leakage values for a detergent, Triton X-100 at L/P = 5.37, are shown.  The error bars represent S.D. 
(n = 2).  pH-dependence was not observed for either 0Dap or 8Dap. 
 
Figure 10 Global fitting of the viability of PANC-1 cells in the presence of 8Dap under different pH conditions.  
Solid curves indicate theoretical curves by eq. (5) with fitting parameters in Table 4.  Medium pH values are 
indicated in the figure. 
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Table-of-Contents text 
By introducing the nonproteinogenic amino acid Dap, a pH-responsive anticancer peptide was developed.  It 
exerted over 10-fold increased toxicity at pH 6.0 specific to cancer tissues compared to that at pH 7.4.  This 
strategy will lead to a new mechanism of cancer tissue targeting to enhance cancer selectivity. 
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Figure S1. Helical wheel representation of each peptide.  The diagrams were generated with a script developed 
by Alan R. Mól, Wagner Fontes, Mariana S. Castro, Universidade de Brasília – Brazil 
(http://lbqp.unb.br/NetWheels/).  Yellow hexagons, green triangles, red diamonds and blue circles represent 






Figure S2 Toxicities of the Alexa488-labeled peptides compared to those of the free-peptides.  The peptide 





Figure S3 The ability of Dap-containing peptides to induce endosomal escape of cargos.  
FITC-dextran (70 kDa) was used as a marker.  The peptide (10 µM) and FITC-dextran (250 µg 
mL–1) were co-incubated with PANC-1 cells for 1 h in culture medium.  After washout of the 
dextran and an additional incubation for 3 h, the cells were observed by confocal microscopy.  Left 
and right panels show percentages of cells that exhibited significant vesicular uptake of dextran and 
dextran diffusion into the cytosol, respectively (n = 186, 358, 258, and 235 for vehicle, 8Dap, 6Dap, 
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